Neurologist Advisory Board Member

Neurologist Advisory Board Member

About Neurogenesis Neurogenesis is a clinical-stage biotechnology company developing NG01, an autologous bone marrow–derived cell therapy designed to promote remyelination and neurological repair in Progressive Multiple Sclerosis (MS).

Over 120 patients have been treated across multiple clinical trials, including randomized, placebo-controlled studies. NG01 has demonstrated safety and signals of functional improvement, and a U.S. FDA-cleared Phase 2b trial will commence this year at leading academic medical centers.

Neurogenesis is backed by institutional investors and is advancing toward global commercialization.

Role Overview We are expanding our Neurologist Advisory Board and seeking experienced neurologists with expertise in MS and neurodegenerative disease who are interested in supporting an innovative neurorepair platform.

This is a light-commitment role requiring approximately 1–2 hours per month. It is designed for practicing clinicians who want to contribute strategically without operational burden.

Advisory Contributions • Serve as a clinical champion and thought partner • Provide high-level input on company strategy and business plan • Offer perspective on evolving standards of care and market dynamics • Support long-term clinical and commercialization vision • Make selective introductions within the neurology ecosystem when appropriate

Ideal Background • Board-certified Neurologist • Experience treating MS or related neurodegenerative disorders • Interest in regenerative medicine and neurological repair • Strategic mindset and enthusiasm for innovation

Why Join • Help shape a potential first-in-class neurorepair therapy • Engage directly with an experienced biotech leadership team • Option to invest alongside institutional backers • Remote, flexible commitment (1–2 hours per month)

If you are interested in helping redefine what’s possible in Progressive MS, apply today.